MARKET

PAVM

PAVM

PAVmed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.170
+0.160
+7.96%
After Hours: 2.180 +0.01 +0.46% 19:39 08/13 EDT
OPEN
2.040
PREV CLOSE
2.010
HIGH
2.200
LOW
1.990
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
3.450
52 WEEK LOW
0.8100
MARKET CAP
107.06M
P/E (TTM)
-2.8590
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PAVM stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

EPS

PAVM News

More
PAVmed Secures $7 Million Convertible Note Financing
NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced it has received approximately $7 million in gross procee
GlobeNewswire · 08/06 13:27
PAVmed to Hold Business Update Conference Call on August 18, 2020
NEW YORK, July 28, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company will host a business update conference
GlobeNewswire · 07/28 13:30
Edited Transcript of PAVM earnings conference call or presentation 21-May-20 8:30pm GMT
Q1 2020 PAVmed Inc Earnings Call
Thomson Reuters StreetEvents · 07/14 20:20
PAVmed to Present at Maxim Group’s COVID-19 Webinar on July 16, 2020
NEW YORK, July 13, 2020 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today.
GlobeNewswire · 07/13 13:30
PAVmed Granted US Patent Titled 'Continuous flow balloon catheter systems and methods of use'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10687883.PN.&OS=PN/10687883&RS=PN/10687883
Benzinga · 06/23 14:07
PAVmed to Join the Russell 2000® and Russell 3000® Indexes
GlobeNewswire · 06/17 14:30
PAVmed to Join the Russell 2000, Russell 3000 Indexes
Benzinga · 06/17 13:32
Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor
GlobeNewswire · 06/15 14:30

Industry

Advanced Medical Equipment & Technology
+0.81%
Healthcare Equipment & Supplies
+0.69%

Hot Stocks

Symbol
Price
%Change

About PAVM

PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. CarpX is a percutaneous device to treat carpal tunnel syndrome. NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions. The Company is engaged in developing disposable infusion system with variable flow resistors. Caldus is a disposable tissue ablation device.
More

Webull offers kinds of PAVmed Inc stock information, including NASDAQ:PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAVM stock methods without spending real money on the virtual paper trading platform.